InvestorsHub Logo

daruma

11/26/18 2:44 PM

#88384 RE: twaflyer1 #88383

That's an interesting take. For you, is this specifically for MJ or all "vice" stocks?

klhurley

11/27/18 12:47 PM

#88390 RE: twaflyer1 #88383

twaflyer1,

I agree with you 100% about MJ stocks on principal. That is why I looked very carefully at CBD oil and its benefits. It doesn't give you the 'high' and mess with your brain like the THC part of MJ does.

That is the only reason I'm OK with this particular play.

https://www.cnbc.com/2018/11/09/what-is-cbd-these-popular-cannabis-products-wont-get-you-high.html

From the article, it has tremendous benefits:

"Still, CBD is already commonly used to relieve some symptoms of anxiety, including insomnia, and there have been some studies that show it to be effective in those cases. Other studies have shown that CBD could have anti-inflammatory properties, and many CBD products are marketed for relieving chronic pain, such as arthritis. And multiple studies have found CBD to be an effective treatment for seizures, and there are various CBD products that are used by patients with epilepsy.

For what it's worth, in December 2017, the World Health Organization declared in a report that "cannabidiol does not appear to have abuse potential or cause harm." The WHO also noted that CBD could have "therapeutic value" for epileptic seizures, but that further study is warranted to determine CBD's potential medical use.
"

The fact that the FDA approved GW Pharmaceutical's Epidiolex, a CBD-based drug for treating epileptic seizures and is a Class 5 drug, which is entirely derived from MJ components is a great sign for me.